| scholarly article | Q13442814 |
| P50 | author | Abraham Peedicayil | Q51757103 |
| P2093 | author name string | Anitha Thomas | |
| Rachel Chandy | |||
| Bijesh Yadav | |||
| Ajit Sebastian | |||
| Gigi Varghese | |||
| P2860 | cites work | A defunctioning ileostomy does not prevent clinical anastomotic leak after a low anterior resection: a prospective, comparative study | Q81019734 |
| Pelvic drainage and other risk factors for leakage after elective anterior resection in rectal cancer patients: a prospective study of 978 patients | Q81204524 | ||
| Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study | Q81249173 | ||
| Hartmann procedure: is it still relevant today? | Q81826539 | ||
| Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths | Q28241157 | ||
| The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study | Q30418957 | ||
| Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator | Q30729206 | ||
| Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study | Q33348987 | ||
| Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 | ||
| Peritoneal carcinosis of ovarian origin. | Q34391112 | ||
| Cancer in women. | Q35538504 | ||
| Bowel surgery for epithelial ovarian cancer--an early case series | Q35588645 | ||
| Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer | Q36253921 | ||
| What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? | Q36484029 | ||
| "Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary | Q36550812 | ||
| Multiple large bowel resections: potential risk factor for anastomotic leak | Q36941095 | ||
| Imaging ovarian cancer and peritoneal metastases--current and emerging techniques | Q37729815 | ||
| Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review | Q37867595 | ||
| Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes. | Q38007298 | ||
| The evaluation of intra- and postoperative complications related to debulking surgery with bowel resection in patients with FIGO stage III-IV ovarian cancer. | Q44733127 | ||
| Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study | Q46415035 | ||
| Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. | Q46521949 | ||
| Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma | Q52438885 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Surgical indications for combined partial rectosigmoidectomy in ovarian cancer. | Q53644580 | ||
| Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer. | Q54951150 | ||
| Carcinoma of the ovary | Q56779642 | ||
| Risk factors for anastomotic failure after total mesorectal excision of rectal cancer | Q62628676 | ||
| The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer | Q72644277 | ||
| Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma | Q73368616 | ||
| Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study | Q73739424 | ||
| Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? | Q73876538 | ||
| Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer | Q74590464 | ||
| Radical Oophorectomy with Primary Stapled Colorectal Anastomosis for Resection of Locally Advanced Epithelial Ovarian Cancer | Q79106584 | ||
| Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy | Q79135872 | ||
| Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A | Q80070150 | ||
| The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer | Q80155214 | ||
| Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer | Q80407311 | ||
| P433 | issue | 4 | |
| P921 | main subject | ovarian carcinoma | Q18556145 |
| P304 | page(s) | 511-518 | |
| P577 | publication date | 2018-07-20 | |
| P1433 | published in | Indian Journal of Surgical Oncology | Q26841988 |
| P1476 | title | Outcome of Bowel Resection in Women with Advanced Ovarian Carcinoma | |
| P478 | volume | 9 |
Search more.